| Literature DB >> 25220596 |
J M Zimmerer1, P Swamy, P B Sanghavi, C L Wright, M Abdel-Rasoul, S M Elzein, R R Brutkiewicz, G L Bumgardner.
Abstract
We previously reported that posttransplant alloantibody production in CD8-deficient hosts is IL-4+ CD4+ T cell-dependent and IgG1 isotype-dominant. The current studies investigated the hypothesis that IL-4-producing natural killer T cells (NKT cells) contribute to maximal alloantibody production. To investigate this, alloantibody levels were examined in CD8-deficient WT, CD1d KO and Jα18 KO transplant recipients. We found that the magnitude of IgG1 alloantibody production was critically dependent on the presence of type I NKT cells, which are activated by day 1 posttransplant. Unexpectedly, type I NKT cell contribution to enhanced IgG1 alloantibody levels was interferon-γ-dependent and IL-4-independent. Cognate interactions between type I NKT and B cells alone do not stimulate alloantibody production. Instead, NKT cells appear to enhance maturation of IL-4+ CD4+ T cells. To our knowledge, this is the first report to substantiate a critical role for type I NKT cells in enhancing in vivo antibody production in response to endogenous antigenic stimuli. © Copyright 2014 The American Society of Transplantation and the American Society of Transplant Surgeons.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25220596 PMCID: PMC4207222 DOI: 10.1111/ajt.12922
Source DB: PubMed Journal: Am J Transplant ISSN: 1600-6135 Impact factor: 8.086